PMI launches first airport-exclusive IQOS edition

Philip Morris International (PMI) and Altria have signed contract manufacturing deals to boost exports and imports. Altria will benefit from a tax rebate, while PMI maintains no U.S. sales plans. First shipments are expected in 2027, with no impact on 2026 performance. Altria expects a profit boost in late 2026 from similar partnerships.

Philip Morris International and Altria have signed contract manufacturing deals to boost cigarette imports and exports. Altria will benefit from a U.S. tax rebate, while PMI maintains no U.S. sales plans. First shipments are expected in 2027, with no 2026 performance impact. Altria expects a 2026 profit boost from similar partnerships.

Philip Morris International (PM) received FDA approval for 11 ZYN ULTRA nicotine pouches. The authorization expands the company's portfolio of alternatives for adult smokers or traditional oral tobacco users. The approval follows a scientific review by the FDA.

The FDA authorized 11 ZYN ULTRA nicotine pouches from Philip Morris International's (PM) affiliate, Swedish Match. The products include 9mg and 11mg variants. PM plans to expand its portfolio, aiming to capture the U.S. nicotine market.

The FDA authorized the marketing of 11 ZYN ULTRA nicotine pouch products from Philip Morris International's (PM) U.S. affiliate, Swedish Match USA. The authorized products include 9mg and 11mg variants, with additional 11mg variants under review. This expands PM's portfolio of smoke-free alternatives, reinforcing its leadership in the category. The company aims to provide better choices for nicotine consumers, with ZYN being the first nicotine pouch authorized for sale in the U.S. following rigo

Philip Morris Korea will launch its VEEV e-vapor product in South Korea on Aug. 26. The company aims to expand its smoke-free portfolio, with 42% of Philip Morris International's Q2 revenue coming from smoke-free products. The company targets 66% of sales from smoke-free products by 2030.